Clinical Trials Logo

Clinical Trial Summary

Currently, successful prevention of migraine is not sufficiently achieved by (prophylactic) drug therapy. In contrast, neurophysiologically guided treatments might provide an alternative avenue, since these can normalize brain alterations without side effects. Transcranial direct current stimulation (tDCS) appears useful in the acute and prophylactic treatment of migraine, probably because of its modifying and re-balancing influence on neuronal activity. Yet, to test for the efficacy of tDCS in a clinically acceptable way, it is necessary to apply not only tDCS but also a "sham" placebo, which is often neglected in tDCS stimulation studies. Further, tDCS needs to be applied in a large (n > 20) sample of well-defined migraine patients, which would be advantageous, compared to previously published work. Monitoring sources of regional neuronal alterations in migraineurs prior and after tDCS is essential to investigate physiological mechanisms of tDCS. There is an increasing interest towards non-pharmacological treatment alternatives for migraine (and headache disorders) with reduced side effects to established prophylactic medications. The primary outcome of this project is to demonstrate that repetitive sessions of neurostimulation lead to a significant and permanent reduction of the primary symptom severity (i.e. migraine attacks) for patients suffering from chronic and episodic migraine. Since neurostimulation tools are nowadays accepted as therapeutic tools, our study might provide evidence that tDCS can be a non-pharmacological alternative for treating migraine.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03237754
Study type Interventional
Source University of Zurich
Contact
Status Terminated
Phase N/A
Start date October 1, 2016
Completion date May 30, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05060484 - A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years Phase 2
Recruiting NCT04780399 - Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease Phase 2
Completed NCT05373797 - The Effect of Virtual Reality Glasses Used During Burn Dressing in Children on Parents' Satisfaction Level and Anxiety
Completed NCT05490693 - The Effect of Virtual Reality Glasses Used During Burn Dressing in Children on Pain, Anxiety and Fear
Active, not recruiting NCT00533000 - Smoking Cessation and Postoperative Complications N/A
Completed NCT04791605 - Gait Pattern Between a Cemented and Non-cemented Femur Stem N/A
Recruiting NCT05812560 - Evaluation of a Protocol Posturalchanges in Women Giving Birth With Epidural Analgesia. Clinical Trial. N/A
Active, not recruiting NCT01738074 - Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine Phase 3
Terminated NCT03060460 - Ultrasound Guided Insertion of Sheath Before Angiography or Angioplasty N/A
Not yet recruiting NCT04825340 - To Explore a Bridging Index for the Effectiveness of the Clinical Trial N/A